Neuren biotech rockets on Rett Syndrome trials news

MELBOURNE: Neurological disease biotech Neuren has jumped as much as 109 per cent ... read more

Imugene moves forward with cancer vax trial news release

MELBOURNE: Paul Hopper’s $2.7 billion cancer biotech Imugene will move forward with trials ... read more

Woolworths battle to take Priceline could change pharmacy market

MELBOURNE: Across the world, from the UK to the US and New Zealand ... read more

Woolworths facing a harder road in API tilt

MELBOURNE: Analysts say supermarket giant Woolworths has a harder road to travel than ... read more